Market Cap (In USD)
968.15 Million
Revenue (In USD)
566.76 Million
Net Income (In USD)
48.15 Million
Avg. Volume
419.17 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 28.97-42.287
- PE
- -
- EPS
- -
- Beta Value
- 0.949
- ISIN
- US19459J1043
- CUSIP
- 19459J104
- CIK
- 1267565
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.
- Employee Count
- -
- Website
- https://www.collegiumpharma.com
- Ipo Date
- 2015-05-07
- Details
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
More Stocks
-
MICELMIC Electronics Limited
MICEL
-
EDXCEndexx Corporation
EDXC
-
002778
-
GWH-WTESS Tech, Inc. WT
GWH-WT
-
002448ZYNP Corporation
002448
-
CFFS
-
603722
-
CMFO